|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 0.8500 EUR | -2.30% |
|
-4.71% | -37.68% |
| 18.06. | AB Science sichert sich US-Patent für Therapie gegen Prostatakrebs | MT |
| 18.06. | AB Science sichert sich neues US-Patent für Masitinib |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.36% | -4.35% | +0.77% | -0.27% | +8.18% | +44.03% | +3.30% | +48.64% | +102.83% | 281 Mrd. | ||
| -0.11% | -0.26% | +8.27% | +27.73% | +8.40% | +20.49% | -14.40% | -12.57% | +49.14% | 66.27 Mrd. | ||
| +1.30% | +5.71% | +6.71% | +8.07% | +0.42% | +2.24% | -7.88% | -32.87% | +40.89% | 8.24 Mrd. | ||
| -0.03% | -1.37% | -0.62% | +8.07% | +1.86% | +29.80% | +98.29% | +65.54% | +688.38% | 8.13 Mrd. | ||
| -1.92% | -1.02% | -4.40% | -11.76% | -30.18% | -6.35% | +4.44% | -31.76% | - | 4.45 Mrd. | ||
| -2.69% | -1.42% | -6.63% | -24.13% | -32.30% | -26.97% | +36.12% | +37.65% | +81.93% | 3.71 Mrd. | ||
| +8.33% | +2.08% | +12.59% | +29.06% | +17.76% | +0.22% | +12.14% | -45.83% | - | 3.42 Mrd. | ||
| +1.84% | -0.07% | -8.85% | -7.08% | -10.70% | +37.48% | +32.32% | +38.30% | +142.38% | 2.58 Mrd. | ||
| -1.01% | -2.64% | -19.22% | -22.10% | -24.83% | +5.02% | -26.66% | -4.89% | - | 1.92 Mrd. | ||
| +2.09% | +0.71% | -12.37% | -13.21% | -12.97% | +20.12% | +18.22% | -38.86% | - | 1.66 Mrd. | ||
| -.--% | -.--% | - | - | - | - | - | - | - | 1.64 Mrd. | ||
| -2.03% | -5.86% | -10.58% | -21.31% | -18.81% | -21.61% | -27.18% | -16.33% | -42.94% | 1.62 Mrd. | ||
| +3.84% | -2.51% | -29.01% | -21.06% | -13.17% | -7.36% | -24.27% | - | - | 1.23 Mrd. | ||
| -2.84% | -4.79% | -11.87% | -32.75% | -31.63% | +47.02% | +98.07% | +33.91% | +470.37% | 1.22 Mrd. | ||
| +4.48% | +1.58% | -16.63% | +2.02% | +3.32% | +93.46% | +77.11% | -15.30% | - | 1.03 Mrd. | ||
| -0.63% | +1.02% | +1.94% | -13.01% | -15.16% | -4.01% | +32.61% | +85.82% | +87.14% | 1.01 Mrd. | ||
| +0.43% | -6.04% | -12.43% | -16.95% | -16.21% | +75.25% | -20.45% | -72.60% | -94.71% | 961 Mio. | ||
| -6.31% | -4.99% | -4.38% | -33.66% | -17.81% | +31.27% | +66.97% | +1.23% | +247.20% | 928 Mio. | ||
| -0.85% | +2.82% | -5.72% | +45.52% | +92.08% | +139.35% | +720.20% | +443.14% | - | 890 Mio. | ||
| Durchschnitt | +0.13% | -1.69% | -6.25% | -5.38% | -5.10% | +26.64% | +59.94% | +28.43% | +161.15% | 20.64 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.94% | -4.23% | +1.61% | +4.22% | +6.50% | +36.73% | +4.63% | +34.38% | +105.11% |
- Börse
- Aktien
- A1CXBG Aktie
- A1CXBG Aktie
- Sektor AB Science
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















